Herold Advisors, Inc. Pfizer Inc Transaction History

Herold Advisors, Inc.

$449 Million
Q3 2024

A detailed history of Herold Advisors, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Herold Advisors, Inc. holds 68,258 shares of PFE stock, worth $1.7 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

68,258

Previous 62,076 9.96%

Holding current value

$1.7 Million

Previous $1.74 Million 13.77%

% of portfolio

0.44%

Previous 0.41%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $171,241 - $194,052	6,182 Added 9.96%	68,258 $1.98 Million
Q2 2024 Jul 24, 2024	BUY	$25.26 - $29.6 $150,473 - $176,327	5,957 Added 10.61%	62,076 $1.74 Million
Q1 2024 May 10, 2024	SELL	$25.89 - $29.73 $197,877 - $227,226	-7,643 Reduced 11.99%	56,119 $1.56 Million
Q4 2023 Feb 02, 2024	BUY	$26.13 - $33.94 $26,809 - $34,822	1,026 Added 1.64%	63,762 $1.84 Million
Q3 2023 Nov 08, 2023	BUY	$32.09 - $37.51 $311,625 - $364,259	9,711 Added 18.31%	62,736 $2.08 Million
Q2 2023 Jul 14, 2023	BUY	$36.12 - $41.79 $109,588 - $126,790	3,034 Added 6.07%	53,025 $1.94 Million
Q1 2023 Apr 19, 2023	BUY	$39.39 - $51.28 $618,816 - $805,608	15,710 Added 45.83%	49,991 $2.04 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $91,015 - $118,810	2,180 Added 6.79%	34,281 $1.76 Million
Q3 2022 Nov 08, 2022	BUY	$43.76 - $53.42 $13,959 - $17,040	319 Added 1.0%	32,101 $1.4 Million
Q2 2022 Jul 15, 2022	SELL	$46.53 - $55.17 $78,496 - $93,071	-1,687 Reduced 5.04%	31,782 $1.67 Million
Q1 2022 May 09, 2022	BUY	$45.75 - $56.69 $22,371 - $27,721	489 Added 1.48%	33,469 $1.73 Million
Q4 2021 Jan 20, 2022	BUY	$41.32 - $61.25 $36,485 - $54,083	883 Added 2.75%	32,980 $1.95 Million
Q3 2021 Nov 03, 2021	BUY	$39.25 - $50.42 $1.26 Million - $1.62 Million	32,097 New	32,097 $1.38 Million

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $140B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Herold Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Herold Advisors, Inc. with notifications on news.

Account

Herold Advisors, Inc. Pfizer Inc Transaction History